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Improved referral and survival of newborns
after scaling up of intensive care in
Suriname
Rens Zonneveld1,2,3 , Natanael Holband1, Anna Bertolini4, Francesca Bardi4, Neirude P. A. Lissone1, Peter H. Dijk4,
Frans B. Plötz3 and Amadu Juliana1*
Abstract
Background: Scaling up neonatal care facilities in developing countries can improve survival of newborns.
Recently, the only tertiary neonatal care facility in Suriname transitioned to a modern environment in which
interventions to improve intensive care were performed. This study evaluates impact of this transition on referral
pattern and outcomes of newborns.
Methods: A retrospective chart study amongst newborns admitted to the facility was performed and outcomes of
newborns between two 9-month periods before and after the transition in March 2015 were compared.
Results: After the transition more intensive care was delivered (RR 1.23; 95% CI 1.07–1.42) and more outborn
newborns were treated (RR 2.02; 95% CI 1.39–2.95) with similar birth weight in both periods (P=0.16). Mortality of
inborn and outborn newborns was reduced (RR 0.62; 95% CI 0.41–0.94), along with mortality of sepsis (RR 0.37; 95%
CI 0.17–0.81) and asphyxia (RR 0.21; 95% CI 0.51–0.87). Mortality of newborns with a birth weight <1000 grams (34.
8%; RR 0.90; 95% CI 0.43–1.90) and incidence of sepsis (38.8%, 95% CI 33.3–44.6) and necrotizing enterocolitis (NEC)
(12.5%, 95% CI 6.2–23.6) remained high after the transition.
Conclusions: After scaling up intensive care at our neonatal care facility more outborn newborns were admitted
and survival improved for both in- and outborn newborns. Challenges ahead are sustainability, further
improvement of tertiary function, and prevention of NEC and sepsis.
Keywords: NICU, Low-resource setting, Developing country, Neonatal mortality, Suriname
Background
Neonatal mortality in developing countries continues to
be a chief global health challenge [1, 2]. A recent global
report indicates that over 40% reduction of neonatal
mortality can be achieved by implementation of institu-
tional care in lower resource countries [3]. In particular,
local or regional neonatal care facilities with integrated
availability of perinatal and neonatal intensive care can re-
duce mortality [4]. For example, newborns born in a rural
hospital featuring a neonatal intensive care unit (NICU) in
Uganda were almost twice as likely to survive than those
born outside [5]. Moreover, introduction of a neonatal care
facility in a low-income district in India reduced neonatal
mortality rate (NMR) by 21% after the first two years [6].
Improving interventions within existing neonatal care facil-
ities (e.g., training of personnel, refurbishment, infection
prevention) can improve mortality and enhance tertiary
function for newborns in need of intensive care [6–9].
In Suriname NMR in 2009 was 16.0 per 1000 live
births. However, detailed data on demographics and out-
comes of newborns are lacking. In 2008 the neonatal
care facility at the Academic Hospital Paramaribo
(AHP), which also incorporated the first and only NICU
in Suriname, opened its doors. The ability to treat pre-
mature and critically ill newborns was an important step
towards reducing mortality. At the end of March 2015
the facility moved to a new and modern environment.
This transition solidified availability of neonatal intensive
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care in Suriname with reinforcement and training of
personnel, new equipment, continuous availability of
supplies, and protocol-based care. Since this facility is
the only referral center for newborns requiring intensive
care in Suriname, morbidity and mortality of newborns
treated here reflect their outcomes at the national level.
Therefore, as a benchmark for future investigations, we
developed a registry to describe demographics and out-
comes of newborns admitted to the neonatal care facility.
Additionally, to evaluate the impact of improvements we
compare referral pattern, mortality and morbidity of new-
borns treated in periods before and after the transition.
Ultimately, this could lead to better prospective registry
and care for critically ill newborns in Suriname.
Methods
Study design
We performed a retrospective (pre-and post transition)
study in the neonatal care facility of the AHP during the
periods July 1st 2014 to March 29th 2015 (Period 1) and
March 31st to December 31st 2015 (Period 2). The im-
pact of the transition was described by analyzing demo-
graphics and outcomes of all inborn and outborn
newborns admitted within these two periods. Excluded
were newborns whom were treated in both periods and
of whom insufficient information (i.e., no or incomplete
paper charts) was available to confirm outcomes. We re-
ceived a waiver from our institutional ethical board.
Setting and interventions
Suriname is a small middle-income country with a multi-
ethnic society and has an annual birth rate of about
10,000 births. Over 90% of births take place at delivery
rooms of one of four hospitals situated in Suriname’s cap-
ital Paramaribo (inhabited by more than half of Suriname’s
population). About 30% of births take place at the delivery
room of the AHP. The neonatal care facility at the AHP
serves as the only referral hospital for critically ill new-
borns. Since the opening in 2008, between 350 and 400
newborns are treated each year in one room with 12 beds,
with NICU capacity operating at Level III [9]. Newborns
are generally only actively treated with a birth weight
(BW) ≥ 750 g and/or gestational age (GA) ≥ 27 weeks.
On March 30th 2015 the facility moved to a com-
pletely new, modern and spacious environment with
central climate control and new equipment (i.e., ventila-
tors, incubators, air-humidifiers, ultrasound machines
and multi-parameter monitors). Capacity for mechanical
ventilation and continuous positive airway pressure
(CPAP) was doubled. The NICU (6 beds), high care
(HC) (6 beds), and medium care (MC) (4 beds) capacity
in the new facility remained the same until February
2016 (when a separate space for the MC was opened
and the NICU capacity increased to 10 beds).
Total expense for the new building and equipment
was 2.6 million US dollars. Funds were collected from
kind donations from governmental and private organiza-
tions and from Surinamese companies. Since there were
no architects or contractors available within Suriname
with experience in designing a NICU level neonatal care
facility, we relied on guidelines from developed countries
and local creativity and practical experience to realize
the project within budget, without the need for expen-
sive consultants. For example, one of the savings came
from using venturi mechanism based suction devices
powered by compressed air, avoiding the need for a sep-
arate central vacuum system.
Admission criteria remained the same. Obstetric nurses
were trained in neonatal life support and the number of
residents in the obstetric and pediatric department was in-
creased. For both day and evening shifts a separate resi-
dent was assigned to the NICU exclusively. Shortly before
the transition, nurses were trained in intensive neonatal
care and their number was expanded to 1 per 3 or 4 beds.
New charts for vital signs, ventilation settings, and fluid
management were implemented. A breast-feeding and nu-
trition program was started to help reduce cases of necro-
tizing enterocolitis (NEC) and mothers were allowed at
the bedside twice as long as before. Systematic infection
prevention (i.e., stringent guidelines and more facilities for
hand washing, providing of patient specific (disposable)
materials, Extended Spectrum Beta-Lactamase (ESBL)
outbreak control) was enforced.
Data collection and analysis
Data were collected from paper medical records on mater-
nal, obstetric and perinatal history, birth location, reason for
admission, hospital course, and outcomes. A single major
cause of death was determined. For each included newborn
we determined the highest level of care during their stay by
assigning criteria for NICU, HC or MC retrospectively
according to local protocol (Additional file 1: Table S1).
Primary outcome was mortality: NMR at the AHP and at
the neonatal care facility divided in early (i.e., in-hospital
death before 7 days of life) and late (i.e., in-hospital death of
at term newborns after 7 days of life), GA-specific mortality,
BW-specific mortality, and cause-specific mortality. Second-
ary outcomes were highest level of care, respiratory treat-
ments (CPAP, mechanical ventilation, surfactant), use of
antibiotics, development of respiratory complications, i.e.,
pneumothorax, bronchopulmonary dysplasia (BPD; i.e., oxy-
gen dependence >28 days of age), ventilator-associated pneu-
monia (VAP; i.e., positive tracheal aspirate culture after
ventilation), development of NEC and sepsis (i.e., early
(<72 h after birth) and late (>72 h after birth) onset clinical
(i.e., clinical suspicion, treated with antibiotics for 7 days,
raised c-reactive protein levels)) and blood culture positive
sepsis, blood and ESBL culture results, and duration of stay.
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Statistical analysis
Incidence rates and epidemiological determinants were
calculated for the inclusion period. Categorical variables
are presented as numbers and percentages with 95% con-
fidence intervals (CI) and continuous variables as means
with standard deviations (SD) or, if not normally distrib-
uted, as medians with ranges. Continuous variables were
compared with a student t-test and categorical variables
were compared with Chi-Square. Relative risk (RR) and




A total of 626 newborns were treated at the neonatal care
facility of whom 601 (320 before and 281 after the transi-
tion) were included (Table 1). Overall demographics were
comparable between both periods, with similar percent-
ages of missing data, showing high prevalence of (ante-
natal) risk factors for mortality and morbidity (Table 1). In
period 2 significantly more outborn newborns (RR 2.02;
95% CI 1.39–2.95; P < 0.001) were treated with similar
mean birthweight (2183 ± 845 g vs. 1915 ± 990 g;
P = 0.16). Prematurity was the main reason for admission
for all inborn (48.3%; 95% CI 44.0–52.7) and outborn
(66.0%; 95% CI 56.3–74.5) newborns, followed by respira-
tory distress and suspected infection (Table 1).
Mortality
NMR of inborn newborns born at the AHP was lower in
period 2 (P = 0.02) (Table 2). After the transition, reduc-
tion in mortality was greatest in newborns treated at
NICU level care (P < 0.01), with a GA above 28 weeks (RR
0.42; 95% CI 0.25–0.72; P = 0.002), and outborn newborns
(P = 0.02). A trend in decrease in mortality was observed
in late mortality (P = 0.06), inborn newborns (P = 0.07),
and in newborns with a birth weight (BW) above 1500 g
(P = 0.07). A significant reduction in mortality was ob-
served in cases of sepsis (P = 0.01) and perinatal asphyxia
(P = 0.03). Sepsis was the main cause of death in period 1
(34.5%; 95% CI 23.4–47.7), and second in period 2 (26.7%;
95% CI 14.2–44.4). For newborns with a BW < 1000 g
late-onset sepsis was the main cause of death in both pe-
riods (44.8%; 95% CI 28.4–62.5).
Treatments and morbidity
Based on our criteria (Additional file 1: Table S1) signifi-
cantly more NICU level care was given in period 2
(P < 0.01) (Table 3). More mechanical ventilation and
surfactant were applied after the transition. No differ-
ence in prevalence of VAP or pneumothorax was ob-
served and there was a trend in increases incidence of
BPD (P = 0.07) (Table 4). Grade 2 or higher NEC was
present at high incidence in newborns with a BW < 1500 g
in both periods (5.4% and 12.5%, respectively). Sepsis (ei-
ther early or late-onset) was prevalent in over 30% of pa-
tients in both periods, of which half was LOS. During
both periods, outbreaks with ESBL bacteria led to a sig-
nificant prevalence of ESBL positive cultures.
Discussion
Improvements at the neonatal care facility led to an
increase of newborns that received intensive care with a sig-
nificant reduction in their mortality. Furthermore, new-
borns with a GA above 28 weeks and/or BW ≥ 1500 g
showed a significantly reduced mortality rate. A striking re-
duction in mortality was seen in cases of perinatal asphyxia
and sepsis. In addition, after the transition a two-fold in-
crease in admission of outborn newborns, with similar
demographics and increased survival rates, was observed.
These findings indicate enhanced tertiary function and
centralization of neonatal intensive care in Suriname, which
may play a significant role in reducing neonatal mortality in
Suriname.
Other studies performed in developing countries have
shown similar patterns in improvement of mortality after
scaling up of neonatal care facilities. Creation of a level II
sick newborn care unit (SNCU) (i.e., with introduction of
bed warmers and central oxygen) in a district hospital in
India led to a significant reduction of regional NMR of
mostly newborns with a BW < 1500 g [6]. Another pre-
and-post intervention study in India showed that basic in-
terventions (i.e., promotion of enteral nutrition, asepsis
regulations and training of nurses) led to an immediate
and stable reduction of NMR and birth-weight specific
survival of newborns with a BW < 1500 g, but not with a
BW < 1000 g, primarily after reduced incidence and mor-
tality of sepsis [7]. Introduction of nasal CPAP at a NICU
in Nicaragua reduced mortality amongst total newborns
receiving ventilation assistance (i.e. either mechanical ven-
tilation or CPAP) [8]. Improvement (i.e., new equipment,
refurbishment and training of personnel) of a newborn
unit to a Level III NICU at a teaching hospital in Ghana
led to significant reduction of mortality amongst new-
borns with a BW < 2500 g, mostly secondary to signifi-
cantly reduced incidence of perinatal asphyxia [9].
In these studies, training and expansion of personnel
was a universal denominator for improvement of care,
which was also part of our intervention. Systematic train-
ing of midwives in neonatal resuscitation has been a chal-
lenge in low resource countries and so far has yielded
positive results only in low risk settings, and takes time
with need for strong re-enforcement and repetition before
an effect on neonatal mortality is observed [10–12]. How-
ever, increasing the number of nurses per infant at the
NICU may have a beneficial effect on neonatal outcome
[13, 14]. Further improvement of survival may then be ac-
complished with increased capacity for neonatal intensive
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N % (95% CI) N % (95% CI)
Live births Total at AHP 2353 1972
Admissions to facility Total 331 295
Included 320 96.7 281 95.3
Inborn 284 88.7 (84.8–91.8) 217 77.2 (72.0–81.7)
Outbornb 36 11.3 (8.2–15.2) 64 22.8 (18.3–28.0)
Maternal age
(Years)
<20 54 16.9 (13.2–21.4) 36 12.8 (9.4–17.2)
20–34 168 52.5 (47.0–57.9) 140 49.8 (44.0–55.6)
≥35 46 14.4 (11.0–18.6) 24 8.5 (5.8–12.4)
Missing 52 16.3 81 28.8
Pregnancy HIV 6 1.9 (0.9–4.0) 2 0.7 (0.2–2.6)
Diabetes 18 5.6 (3.6–8.7) 20 7.1 (4.7–10.7)
PIH / Preeclampsia 60 18.8 (14.9–23.4) 62 22.1 (17.6–27.3)
Antenatal steroidsc 47 46.1 (36.7–55.7) 55 53.9 (44.3–63.3)
Infection riskd 47 14.7 (11.2–19.0) 38 13.5 (10.0–18.0)
Mode of delivery Vaginal 187 58.4 (53.0–63.7) 167 59.4 (53.6–65.0)
Caesarean section 105 32.8 (27.9–38.1) 94 33.5 (28.2–39.2)
Missing 28 8.8 20 7.1
Sex Male 162 50.6 (45.2–56.1) 155 55.2 (49.3–60.9)
Female 158 49.4 (43.9–54.8) 126 44.8 (39.1–50.7)
Gestational age (Weeks) <28 16 5.0 (3.1–8.0) 13 4.6 (2.7–7.8)
28–32 48 15.0 (11.5–19.3) 47 16.7 (12.8–21.5)
33–36 114 35.6 (30.6–41.0) 100 35.6 (30.2–41.3)
≥37 132 41.3 (36.0–46.7) 110 39.1 (33.6–45.0)
Missing 10 3.1 11 3.9
Birth weight (Grams) <1000 26 8.1 (5.6–11.6) 23 8.2 (5.5–12.0)
≥1000–1499 48 15.0 (11.5–19.3) 33 11.7 (8.5–16.0)
≥1500 242 75.6 (70.6–80.0) 221 78.6 (73.5–83.0)
Missing 4 1.3 4 1.4
Apgar Score at 5’ <5 24 7.5 (5.1–10.9) 7 2.5 (1.2–5.1)
Missing 45 14.1 47 16.7 (12.8–21.5)
Ethnicity Maroon 87 27.2 (22.6–32.3) 72 25.6 (20.9–31.0)
Creole 85 26.2 (22.0–31.7) 72 25.6 (20.9–31.0)
Hindo-Surinamese 59 18.4 (14.6–23.1) 55 19.6 (15.4–24.6)
Javanese 15 4.7 (2.9–7.6) 21 7.5 (4.9–11.2)
Amerindian 10 3.1 (1.7–5.7) 7 2.5 (1.2–5.1)
Chinese 2 0.6 (0.2–2.2) 2 0.7 (0.2–2.6)
Othere 31 9.7 (6.9–13.4) 32 11.4 (8.2–15.6)
Missing 31 9.7 20 7.1
Initial reason for admissiona Prematurity 152 47.5 (42.1–53.0) 148 52.7 (46.8–58.4)
Respiratory distressf 119 37.2 (32.1–42.6) 122 43.4 (37.7–49.3)
Suspected infectiong 91 28.4 (23.8–33.6) 97 34.5 (29.2–40.3)
Perinatal asphyxiah 39 12.2 (9.0–16.2) 30 10.7 (7.6–14.8)
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N % (95% CI) N % (95% CI)
Congenital malformationsi 42 13.1 (9.9–17.3) 35 12.5 (9.1–16.8)
Otherj 71 22.2 (18.0–27.1) 49 17.4 (13.4–22.3)
AHP Academic Hospital Paramaribo, NICU neonatal intensive care unit, HC high care, MC medium care, PIH pregnancy-induced hypertension, RDS respiratory
distress syndrome
a Newborns could have more than one reason for admission
b Includes: delivery rooms of four other hospitals in Paramaribo and one other hospital in Nickerie, birth clinics in rural and interior parts of Suriname, and
home births
cAdministered in two doses of dexamethasone in the case of suspected premature birth before GA of 34 weeks (calculated for a total of N = 102 newborns in
period 1 and N = 102 in period 2)
dIncludes: premature rupture of membranes (PROM), intrapartum fever and/or antibiotics, positive maternal Group-B streptococcus culture
eIncludes: Caucasian, Brazilian, or mixed
fIncludes: neonatal respiratory distress syndrome, congenital pneumonia, pulmonary hemorrhage, pneumothorax, meconium aspiration syndrome, and transient
neonatal tachypnea
gIncludes: newborns defined with clinical symptoms of infection by admitting physician
hIncludes: asphyxia defined by admitting physician (e.g., in the case of either need for resuscitation or Apgar <5 beyond 5 min; lactate acidosis with base excess
<16; coma or seizures after birth; findings with cerebral ultrasound such as edema)
iIncludes: diaphragmatic hernia, congenital heart defects, gastro-intestinal anomalies and neurological malformations
jIncludes: hypoglycemia, dysmaturity, jaundice, and social indications
Table 2 Mortality of newborns treated at the facility before and after the transition
Period 1 (N = 320)
(July 2014–March 2015)





N % N %
Overall mortality Total at AHP (per 1000 live births)a 23.4 13.2 0.56 (0.36–0.90) 0.02
Total at facility 55/320 17.2 30/281 10.7 0.62 (0.41–0.94) 0.02
Total early neonatal mortality 29/320 9.1 18/281 6.4 0.70 (0.40–1.24) 0.23
Total late neonatal mortality 26/320 8.1 12/281 4.3 0.53 (0.27–1.02) 0.06
Inborn 42/284 14.8 20/217 9.2 0.62 (0.38–1.03) 0.07
Outborn 13/36 36.1 10/64 15.6 0.43 (0.21–0.89) 0.02




<28 weeks 6/16 37.5 8/13 61.5 1.64 (0.76–3.53) 0.20
28–32 weeks 12/48 25.0 5/47 10.6 0.43 (0.16–1.11) 0.08
33–36 weeks 14/114 12.3 4/100 4.0 0.33 (0.11–0.96) 0.04




<1000 g 10/26 38.5 8/23 34.8 0.90 (0.43–1.90) 0.79
≥1000–1499 g 13/48 27.1 6/33 18.2 0.67 (0.28–1.59) 0.36




Sepsisb 19/96 19.8 8/109 7.3 0.37 (0.17–0.81) 0.01
Early-onset sepsis 10/44 22.7 3/59 5.1 0.22 (0.07–0.77) 0.02
Late-onset sepsis 9/52 17.3 5/50 10.0 0.58 (0.21–1.61) 0.29
Perinatal asphyxia 12/38 31.6 2/30 6.7 0.21 (0.51–0.87) 0.03
Prematurity complicationsc 7/157 4.5 5/148 3.4 0.76 (0.25–2.34) 0.63
Congenital malformationsd 12/42 28.6 9/35 25.7 0.90 (0.43–1.88) 0.78
Othere 5 6
AHP Academic Hospital Paramaribo, NICU neonatal intensive care unit
aIncluding deaths at the delivery room (13 before and 6 after the transition)
bIncludes: newborns with clinical suspicion, treated with antibiotics for 7 days, raised c-reactive protein levels, and positive blood culture
cIncludes: respiratory insufficiency or pneumothorax with RDS and extreme prematurity, necrotizing enterocolitis; intraventricular hemorrhage
dIncludes: diaphragmatic hernia, congenital heart defects, gastro-intestinal anomalies and neurological malformations
eIncludes: persistent pulmonary hypertension of the neonate (PPHN), pneumothorax, cardiac tamponade, and kernicterus
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care (e.g., increased capacity for (modernized) ventilation).
We observed a significant increase of use of neonatal in-
tensive care commodities in the post-transition period. In-
deed, both higher level and volume of neonatal intensive
care have been associated with better survival of newborns
with a BW < 1500 g [15, 16]. While this seems an intuitive
and logical effect, it is important to realize that positive ef-
fects of higher capacity can only be sustained with con-
tinuous and balanced availability of trained personnel,
which can be challenging in the lower resource setting
[17, 18]. Illustratively, in our population the reduction of
admission rates in the post transition period coinciding
with increased number of nurses per bed may have been
beneficial for survival. However, the amount of nurses per
infant at our facility is still less than recommended for the
intended level of care (i.e., one nurse per one or two beds),
which may partially explain our finding that the mortality
rate in the most vulnerable small preterm infants (i.e., with
a BW < 1000 g and <28 weeks of GA) did not decrease
[19]. However, restricting the number of beds in case of
understaffing is extremely difficult when there are no
other NICU level referral options in Suriname.
Admission of more outborn neonates indicates an en-
hanced regional function of our neonatal care facility,
which was shown to be beneficial for their survival depend-
ing on the referral system. In Ghana, survival of outborn
newborns at the refurbished NICU was only beneficial to
those referred from private health facilities [9]. In our popu-
lation, outborn newborns, mostly referred from birth clinics
and private or public Level II SNCUs at other hospitals,
died more frequently than inborn ones in both periods. De-
lays in transfer or higher prevalence of antenatal (e.g., pre-
eclampsia) and neonatal (e.g., prematurity) risk factors
could have contributed to this [20–22]. However, the fact
that in our study demographics of outborn newborns were
similar in both periods indicates that better survival after
Table 3 Trends in treatments at the facility in two time periods
Period 1 (N = 320)
(July 2014–March 2015)





N % N %
Highest level of carea NICU 159 49.7 172 61.2 1.23 (1.07–1.42) <0.01
HC 75 23.4 60 21.4 0.91 (0.68–1.23) 0.54
MC 86 26.9 49 17.4 0.65 (0.47–0.87) <0.01
Respiratory treatment CPAP 100 31.3 106 37.7 1.21 (0.97–1.51) 0.10
Mechanical ventilation 38 11.9 55 19.6 1.65 (1.13–2.41) 0.01
Surfactant 15 4.7 21 7.5 1.59 (0.84–3.03) 0.16
Antibiotics received Total 173 54.1 170 60.5 1.12 (0.97–1.29) 0.11
NICU neonatal intensive care unit, HC high Care, MC medium Care, CPAP continuous positive airway pressure
aDetermined with local criteria given in Additional file 1: Table S1
Table 4 Morbidity of newborns treated at the facility in two time periods
Period 1 (N = 320)
(July 2014–March 2015)





N % N %
Respiratory morbidity BPD 4 1.3 10 3.6 2.85 (0.90–8.98) 0.07
VAP 9 2.8 5 1.8 0.63 (0.21–1.87) 0.41
Pneumothorax 4 1.3 7 2.5 1.99 (0.59–6.74) 0.27
NECa Total 10 13.5 12 21.4 1.59 (0.74–3.40) 0.24
≥ Stage 2 4 5.4 7 12.5 2.31 (0.71–7.51) 0.16
Sepsisb Total 96 30.0 109 38.8 1.29 (1.03–1.62) 0.02
Positive blood culture 38 11.9 25 8.9 0.75 (0.46–1.20) 0.24
Positive ESBL culturec Total 34 10.6 39 13.9 1.31 (0.85–2.01) 0.22
Duration of stay (days) Mean SD Mean SD
13 16 14 18 0.44
BPD bronchopulmonary dysplasia, VAP ventilator-associated pneumonia, NEC necrotizing enterocolitis, ESBL extended spectrum beta-lactamase
aCalculated for newborns with a birthweight below 1500 g (N = 74 and N = 56 in period 1 and period 2, respectively)
bIncludes: early and late-onset clinical (i.e., high clinical suspicion, treated with antibiotics for 7 days; raised C-reactive protein levels) and blood culture
positive sepsis
cIncludes: blood and urine cultures and cultures on (tracheal aspirate, skin and anal) swabs, central lines or ventilation tubes
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the transition was mostly due to enhanced neonatal inten-
sive care, independent of presence of antenatal and neo-
natal risk factors. Screening regimens for antenatal risk
factors at surrounding birth clinics and in-utero transfer to
our birth clinic, thereby creating proximity to our neonatal
care facility, could further enhance tertiary function and
improve survival in Suriname [23, 24].
Mortality due to both perinatal asphyxia and sepsis
were reduced in the post transition period. For inborn
newborns, training of obstetric nurses may have contrib-
uted to the reduction in mortality of sepsis and similarly
to less cases and better outcome of asphyxia. Addition-
ally, for both inborn and outborn newborns efficient
treatment (e.g., modern equipment for mechanical venti-
lation or circulatory support) at our refurbished NICU
could have had beneficial effect on survival of both. In
the case of late-onset sepsis, incidence and mortality
remained the same after the transition. This indicates
that our asepsis interventions, aimed primarily at pre-
vention of transmission of pathogens, failed, which is
also reflected in similar amounts of ESBL-positive blood
cultures among both study periods. These results stress
that in our setting strict enforcement of asepsis protocol
remains challenging, but should be prioritized.
Mortality of newborns with a BW < 1000 g remained
high after the intervention. High mortality of newborns
with a BW < 1000 g was also observed in earlier reports in
a Level II SNCU in Jamaica, a Level III neonatal care facil-
ity in South Africa and at multiple NICUs in Brazil and
around the world [1, 25–27]. In our low-resource setting,
the fact that these newborns demand a disproportionate
share of scarcely available human and non-human re-
courses is a significant limitation for improvement. How-
ever, almost half of them died of late-onset sepsis,
indicating that more effective infection prevention, includ-
ing antibiotic stewardship, might substantially increase
their survival rates. Additionally, a major cause for mor-
bidity amongst newborns with a BW < 1500 g in our study
was NEC (Table 4). Prevalence of NEC remained high,
despite promotion of feeding with human breast milk. Re-
cent evidence from NICUs in developed countries has
shown that simple interventions (i.e., early human milk
feedings, rigorous feeding protocol and restricted feeding
during indomethacin treatment and blood transfusions,
and selective antibiotic usage) can reduce incidence of
NEC [28]. These interventions are cost-effective and can
also easily be applied in lower resource settings [29]. A
major limitation in our setting is the unavailability of total
parenteral nutrition, but at the same time the low adher-
ence to breast milk offers a major opportunity for im-
provement. Lastly, the increased number of cases of NEC,
along with the increase in incidence of BPD, may be the
unfortunate effect of more intensive care (e.g., more venti-
lation, more early antibiotics) and better survival.
Limitations to this study were missing data (e.g., scarce
data on additional outcomes such as intraventricular
hemorrhage, retinopathy of the premature, post-discharge
survival), the retrospective nature of this study, and rela-
tively small numbers for complications with a low inci-
dence. Although we collected data to determine the
highest level of care, we were not able to apply an index to
indicate severity of disease of newborns.
Conclusions
This study shows that scaling up of neonatal intensive
care in Suriname substantially reduced mortality of both
in and outborn newborns through its enhanced availabil-
ity and centralization. Challenges ahead are sustainabil-
ity, further improvement of tertiary function, and
prevention of sepsis and NEC with implementation of
cost and resource effective interventions.
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